April 2, 2013
Northbrook-based Astellas Pharma Global Development, a subsidiary of Tokyo-based Astellas Pharma, announced Sef Kurstjens, M.D., PhD., has been promoted to chief medical officer, a new position and will also serve as president of Astellas Pharma Global Development. Kurstjens, who remains president of Astellas affiliate Agensys, will operate out of Northbrook, the company's headquarters for APGD and Astellas in the Americas. Kurstjens joined Agensys, an affiliate of Astellas Pharma Inc., as president in 2010 from Allergan Inc., where he was chief medical officer and head of global drug development. He headed U.S. research and development at Astellas Pharma US, Inc. from 2005-2007. He has also worked at Pfizer and Sandoz, Basel. A native of South Africa, Kurstjens holds a medical degree and a Ph.D. from the University of Witwatersrand Medical School in Johannesburg.